ONMD vs SOPH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

ONMD

47.6
AI Score
VS
ONMD Wins

SOPH

35.3
AI Score

Investment Advisor Scores

ONMD

48score
Recommendation
HOLD

SOPH

35score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric ONMD SOPH Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -29.9% 27.2% SOPH
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 47.6/100 35.3/100 ONMD
Profit Margin -254.3% -93.9% SOPH
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL ONMD

Relative Price Performance (Last 90 Days)

ONMD 1M: -2.4% · 3M: -33.5% SOPH 1M: +47.7% · 3M: +73.2%

Current Technical Phase

ONMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 43

RSI (14): 42.7 · Price: $0.60

SOPH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (16.1% over 20 days), RSI 73

RSI (14): 72.5 · Price: $8.45

Fundamentals Snapshot

Metric ONMD SOPH
Market Cap
Forward P/E 0.0 -16.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.9% 0.3%
Gross Margin -0.8% 0.7%
Operating Margin -7.7% -0.9%
EPS -0.17 -1.16
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ONMD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.